Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (48 quarters reported)
$208M in Q4 2014 → $8.16B now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| SS State Str SPDR S&P 500 ETF T Call | 31.3% | New | 3,350,000 | $2.55B |
| IT Ishares Tr Call | 22.5% | New | 6,600,000 | $1.83B |
| Cytokinetics Inc Call | 2.1% | Added 67% | 2,560,000 | $169M |
| Madrigal Pharmaceuticals Inc Call | 1.6% | New | 255,000 | $129M |
| Agios Pharmaceuticals Inc Call | 1.3% | Added 18% | 3,305,100 | $110M |
| Supernus Pharmaceuticals | 1.3% | Trimmed 3.7% | 2,548,000 | $110M |
| Ptc Therapeutics Inc Call | 1.3% | Added 141% | 1,590,000 | $103M |
| Agios Pharmaceuticals Inc | 1.1% | Added 7.4% | 2,578,000 | $85.7M |
| Ptc Therapeutics Inc | 1.0% | Added 21% | 1,297,510 | $84.1M |
| Neurocrine Biosciences Inc | 1.0% | Added 5.5% | 565,251 | $80.2M |
| Cytokinetics Inc | 1.0% | Trimmed 1.8% | 1,180,192 | $77.8M |
| Travere Therapeutics Inc | 0.9% | Trimmed 18% | 1,289,768 | $75.9M |
| Rigel Pharmaceuticals Inc | 0.9% | Trimmed 8.1% | 1,536,000 | $74M |
| Incyte Corp | 0.9% | Trimmed 33% | 600,045 | $72.8M |
| Neurocrine Biosciences Inc Call | 0.9% | New | 500,000 | $70.9M |
| Ironwood Pharmaceuticals Inc | 0.7% | Added 7.7% | 15,000,000 | $59.6M |
| Immunovant Inc | 0.7% | Added 0.1% | 1,738,169 | $58.7M |
| HB Harmony Biosciences Hldgs In | 0.7% | Trimmed 8.2% | 1,436,000 | $56.4M |
| Immunovant Inc Call | 0.7% | Added 35% | 1,625,000 | $54.9M |
| Freshpet Inc | 0.6% | Trimmed 30% | 888,694 | $51.2M |
| Madrigal Pharmaceuticals Inc | 0.6% | Trimmed 68% | 92,024 | $46.4M |
| Amazon Com Inc | 0.6% | Trimmed 35% | 185,827 | $46.3M |
| Verastem Inc | 0.6% | Trimmed 19% | 5,724,000 | $46.1M |
| Mineralys Therapeutics Inc | 0.5% | Added 1.8% | 1,768,000 | $44.4M |
| Dyne Therapeutics Inc | 0.5% | Trimmed 13% | 2,678,060 | $43.1M |
| Regeneron Pharmaceuticals | 0.5% | Trimmed 37% | 56,736 | $43M |
| Travere Therapeutics Inc Call | 0.5% | Added 44% | 720,000 | $42.4M |
| Nektar Therapeutics | 0.5% | Trimmed 3.3% | 700,000 | $42.4M |
| Mineralys Therapeutics Inc Call | 0.5% | Added 54% | 1,600,000 | $40.2M |
| Mongodb Inc | 0.5% | Trimmed 13% | 108,340 | $37.8M |
| Gsk PLC | 0.4% | Added 141% | 724,000 | $34.9M |
| IH Immunocore Hldgs PLC | 0.4% | Trimmed 20% | 1,136,000 | $34.4M |
| Intuitive Surgical Inc | 0.4% | Added 72% | 83,886 | $34.1M |
| OM Orthofix Med Inc | 0.4% | Added 11% | 3,624,000 | $34.1M |
| SS Sanofi Sa | 0.4% | Trimmed 23% | 824,000 | $34M |
| Uber Technologies Inc | 0.4% | Trimmed 2.3% | 486,649 | $33.3M |
| Microsoft Corp | 0.4% | Trimmed 20% | 64,661 | $33.2M |
| Unitedhealth Group Inc | 0.4% | Trimmed 51% | 90,000 | $33M |
| Disc Medicine Inc | 0.4% | Added 8.7% | 500,000 | $32.7M |
| Alphabet Inc | 0.4% | Trimmed 25% | 95,000 | $32.7M |
| Solid Biosciences Inc | 0.4% | Added 5.1% | 4,496,000 | $32.5M |
| Gitlab Inc | 0.4% | Trimmed 38% | 660,704 | $31.2M |
| Five9 Inc | 0.4% | Trimmed 43% | 876,000 | $29.8M |
| Axogen Inc | 0.4% | Trimmed 11% | 692,000 | $29M |
| Dentsply Sirona Inc | 0.4% | Trimmed 12% | 3,236,000 | $28.7M |
| Intellia Therapeutics Inc | 0.3% | Added 58% | 2,364,000 | $28.5M |
| Wynn Resorts Ltd | 0.3% | Added 37% | 357,036 | $28.4M |
| TM Treace Med Concepts Inc | 0.3% | Unchanged | 6,364,000 | $28.3M |
| 4M 4d Molecular Therapeutics In | 0.3% | Trimmed 2.5% | 1,950,000 | $27.9M |
| AG Alibaba Group Hldg Ltd | 0.3% | Added 49% | 250,000 | $26.9M |
| Autolus Therapeutics Ltd | 0.3% | Trimmed 8.3% | 13,750,000 | $26.7M |
| Align Technology Inc | 0.3% | Trimmed 1.4% | 177,704 | $25.8M |
| Uipath Inc Call | 0.3% | New | 2,000,000 | $25.7M |
| Hubspot Inc Call | 0.3% | New | 125,000 | $25.6M |
| Hubspot Inc | 0.3% | Trimmed 32% | 120,183 | $24.6M |
| Angiodynamics Inc | 0.3% | Trimmed 30% | 1,536,000 | $23.6M |
| M Macrogenics Inc | 0.3% | Added 20% | 6,000,000 | $23.2M |
| Reddit Inc | 0.3% | Added 139% | 160,000 | $22.8M |
| Kura Oncology Inc | 0.3% | Trimmed 43% | 2,096,000 | $22.4M |
| Sentinelone Inc | 0.3% | Trimmed 22% | 934,948 | $22.2M |
Showing top 60 of 346 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed November 16, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS State Str SPDR S&P 500 ETF T | New | +3,350,000 | +$2.55B | 31.3% |
| SS State Str SPDR S&P 500 ETF T | Exited | −3,200,000 | −$2.39B | — |
| IT Ishares Tr | New | +6,600,000 | +$1.83B | 22.5% |
| IT Ishares Tr | Exited | −5,800,000 | −$1.74B | — |
| Madrigal Pharmaceuticals Inc | New | +255,000 | +$129M | 1.6% |
| Madrigal Pharmaceuticals Inc | Trimmed | −195,976 | −$98.8M | 0.6% |
| Neurocrine Biosciences Inc | New | +500,000 | +$70.9M | 0.9% |
| Cytokinetics Inc | Added | +1,030,000 | +$67.9M | 2.1% |
| Thermo Fisher Scientific Inc | Trimmed | −90,490 | −$61.1M | 0.3% |
| Ptc Therapeutics Inc | Added | +930,000 | +$60.2M | 1.3% |
Showing the 10 largest of 474 changes.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS State Str SPDR S&P 500 ETF T | Added | +1,100,000 | +$821M | 29.2% |
| IT Ishares Tr | Added | +2,300,000 | +$691M | 21.3% |
| Travere Therapeutics Inc | Trimmed | −3,324,878 | −$189M | 1.1% |
| Ptc Therapeutics Inc | Trimmed | −1,003,054 | −$81.8M | 1.1% |
| Immunovant Inc | Trimmed | −1,828,916 | −$70.5M | 0.8% |
| Datadog Inc | Trimmed | −170,885 | −$44.5M | 0.1% |
| Cytokinetics Inc | Added | +436,804 | +$37.2M | 1.3% |
| Supernus Pharmaceuticals | Added | +750,854 | +$34.9M | 1.5% |
| Regeneron Pharmaceuticals | Added | +53,683 | +$33.5M | 0.7% |
| SS Sanofi Sa | Added | +764,000 | +$32.6M | 0.6% |
Showing the 10 largest of 413 changes.
quarter ended March 31, 2026 · filed May 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Trimmed | −4,600,000 | −$1.14B | 15.4% |
| SS State Str SPDR S&P 500 ETF T | Trimmed | −900,000 | −$585M | 24.3% |
| Kenvue Inc | Trimmed | −3,962,592 | −$68.3M | — |
| Immunovant Inc | Trimmed | −2,182,239 | −$54.2M | 1.6% |
| Dentsply Sirona Inc | Trimmed | −4,298,000 | −$49.9M | 0.6% |
| Ptc Therapeutics Inc | Trimmed | −727,420 | −$49.6M | 2.5% |
| Argenx Se | Exited | −58,000 | −$48.8M | — |
| GH Ge Healthcare Technologies I | Trimmed | −673,711 | −$48M | 0.1% |
| Starbucks Corp | Exited | −549,805 | −$46.3M | — |
| Supernus Pharmaceuticals | Trimmed | −868,653 | −$44.9M | 1.7% |
Showing the 10 largest of 452 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Tr | Added | +500,000 | +$341M | 24.3% |
| IT Ishares Tr | Added | +1,100,000 | +$271M | 23.7% |
| Travere Therapeutics Inc | Trimmed | −2,960,109 | −$113M | 1.7% |
| Madrigal Pharmaceuticals Inc | Added | +145,723 | +$84.9M | 1.8% |
| Kenvue Inc | New | +3,992,196 | +$68.9M | 0.8% |
| Agios Pharmaceuticals Inc | Added | +2,272,000 | +$61.8M | 1.0% |
| MJ Mdgl Jan6 400.0c | Exited | −130,000 | −$59.6M | — |
| Agios Pharmaceuticals Inc | Added | +2,100,000 | +$57.2M | 1.0% |
| ES Exact Sciences Ord | Exited | −1,030,465 | −$56.4M | — |
| Gsk PLC | New | +1,000,000 | +$49M | 0.6% |
Showing the 10 largest of 493 changes.
quarter ended September 30, 2025 · filed November 17, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SP Supernus Pharmaceuticals Ord | Trimmed | −1,976,000 | −$94.4M | 2.0% |
| PT Ptc Therapeutics Ord | Trimmed | −1,458,192 | −$89.5M | 3.0% |
| DS Dentsply Sirona Ord | Added | +5,234,587 | +$66.4M | 1.1% |
| TT Travere Therapeutics Ord | Trimmed | −2,152,000 | −$51.4M | 2.4% |
| GA Grifols ADR Rep One Non Vtg Cl B Ord | Trimmed | −5,062,000 | −$50.4M | 0.3% |
| Staar Surgical Co | Exited | −2,812,000 | −$47.2M | — |
| NN Novo Nordisk ADR Repsg 1 Ord | New | +736,000 | +$40.8M | 0.6% |
| FO Freshpet Ord | Added | +669,399 | +$36.9M | 1.0% |
| MO Mcdonald's Ord | Trimmed | −119,810 | −$36.4M | 0.1% |
| AF Agio Feb6 40.0 C | New | +900,000 | +$36.1M | 0.5% |
Showing the 10 largest of 376 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Added | +300,000 | +$64.7M | 26.1% |
| Exact Sciences Corp | Trimmed | −1,030,413 | −$54.8M | 0.7% |
| SB Spectrum Brands Hldgs Inc Ne | Exited | −691,000 | −$49.4M | — |
| Simply Good Foods Co | Exited | −1,351,593 | −$46.6M | — |
| Cytokinetics Inc | Trimmed | −1,360,000 | −$44.9M | 0.8% |
| Sensient Technologies Corp | Trimmed | −446,022 | −$43.9M | 0.2% |
| Dominos Pizza Inc | Exited | −90,068 | −$41.4M | — |
| Neurocrine Biosciences Inc | Trimmed | −324,166 | −$40.7M | 1.5% |
| Dentsply Sirona Inc | Trimmed | −2,498,735 | −$39.7M | 0.1% |
| Madrigal Pharmaceuticals Inc | Trimmed | −130,000 | −$39.3M | 0.9% |
Showing the 10 largest of 262 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | New | +300,000 | +$99.4M | 1.5% |
| Vertex Pharmaceuticals Inc | Trimmed | −174,016 | −$84.4M | 0.4% |
| Cytokinetics Inc | Added | +2,090,000 | +$84M | 1.6% |
| IM Inari Med Inc | Exited | −1,565,577 | −$79.9M | — |
| Gsk PLC | Trimmed | −2,000,000 | −$77.5M | 0.2% |
| Anheuser Busch Inbev Sa/nv | Exited | −1,359,000 | −$68M | — |
| Humana Inc | Trimmed | −255,977 | −$67.7M | 0.2% |
| Freshpet Inc | New | +716,960 | +$59.6M | 0.9% |
| Icon PLC | Trimmed | −318,060 | −$55.7M | 0.3% |
| Regeneron Pharmaceuticals | Added | +86,028 | +$54.6M | 1.1% |
Showing the 10 largest of 275 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Added | +1,600,000 | +$354M | 20.5% |
| SS SPDR S&P 500 ETF Tr | Added | +500,000 | +$293M | 20.0% |
| Neurocrine Biosciences Inc | Added | +710,619 | +$97M | 1.7% |
| Exact Sciences Corp | New | +1,617,000 | +$90.9M | 1.2% |
| Icon PLC | New | +418,112 | +$87.7M | 1.2% |
| Cytokinetics Inc | Trimmed | −1,590,000 | −$74.8M | 0.4% |
| Vertex Pharmaceuticals Inc | Added | +177,887 | +$71.6M | 1.2% |
| Gsk PLC | Added | +1,854,000 | +$62.7M | 1.1% |
| Alkermes PLC | Exited | −1,448,654 | −$40.5M | — |
| Ptc Therapeutics Inc | Trimmed | −856,898 | −$38.7M | 3.9% |
Showing the 10 largest of 294 changes.
Loading...